Welcome to LookChem.com Sign In|Join Free
  • or
Benzeneacetic acid, α-(3-methylbutyl)-, also known as 3-methylbutyl phenylacetate or isopentyl phenylacetate, is an organic compound with the chemical formula C13H16O2. It is a colorless to pale yellow liquid with a fruity, apple-like odor. This ester is formed by the reaction of phenylacetic acid and isopentyl alcohol and is commonly used as a fragrance ingredient in various consumer products, such as perfumes, cosmetics, and detergents. It is also employed as a flavoring agent in food and beverages, imparting a sweet, fruity taste. The compound is considered safe for use in these applications, but it is essential to adhere to the recommended concentrations and guidelines to avoid potential health risks.

5558-48-5

Post Buying Request

5558-48-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5558-48-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5558-48-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,5 and 8 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5558-48:
(6*5)+(5*5)+(4*5)+(3*8)+(2*4)+(1*8)=115
115 % 10 = 5
So 5558-48-5 is a valid CAS Registry Number.

5558-48-5Relevant academic research and scientific papers

HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives

Wang, Guangyi,He, Yanzhen,Sun, Jun,Das, Debasis,Hu, Mougang,Huang, Jianhua,Ruhrmund, Donald,Hooi, Lisa,Misialek, Shawn,Ravi Rajagopalan,Stoycheva, Antitsa,Buckman, Brad O.,Kossen, Karl,Seiwert, Scott D.,Beigelman, Leonid

scheme or table, p. 4476 - 4479 (2010/04/05)

2-(1,1-Dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives as potential anti-HCV drugs targeting NS5B polymerase have been investigated. Their synthesis, HCV NS5B polymerase inhibition and replicon activity are discussed.

Novel Inhibitors of Hepatitis C Virus Replication

-

Page/Page column 48-49, (2009/10/21)

The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5558-48-5